NASDAQ
Deciphera Pharmaceuticals, Inc. (DCPH) has a price/fcf ratio of -9.30x as of Monday, May 25, 2026. This represents a 8.44% increase compared to its 12-month average of -10.16x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.